Billionaire Stanley Druckenmiller has now allocated more than a billion dollars to three under-the-radar equities.
New filings show Druckenmiller’s Duquesne Family Office is betting big on stocks in the tech and healthcare sectors.
As of Q1 2025, the firm’s largest position is in Natera Inc. (NTRA), a tech firm specializing in genetic testing for the early detection of hereditary conditions such as cancer. Data shows Duquesne now owns 3.402 million NTRA shares worth about $521.48 million.
Trending: KASH PATEL: Major Arrests Out Of Dallas!
The firm also holds a major position in Teva Pharmaceutical Industries (TEVA), an Israel-based manufacturer of generic medicines. According to the filing, Duquesne has accumulated 14.879 million shares of TEVA worth about $252.955 million.
Druckenmiller has also invested heavily in the South Korean e-commerce giant Coupang Inc. (CPNG). The
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!